JP6019492B2 - 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤 - Google Patents

乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤 Download PDF

Info

Publication number
JP6019492B2
JP6019492B2 JP2010190842A JP2010190842A JP6019492B2 JP 6019492 B2 JP6019492 B2 JP 6019492B2 JP 2010190842 A JP2010190842 A JP 2010190842A JP 2010190842 A JP2010190842 A JP 2010190842A JP 6019492 B2 JP6019492 B2 JP 6019492B2
Authority
JP
Japan
Prior art keywords
lactic acid
cells
acid bacteria
antigen
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010190842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011068643A (ja
JP2011068643A5 (enExample
Inventor
絢子 稲嶺
絢子 稲嶺
美孝 岡本
美孝 岡本
茂俊 堀口
茂俊 堀口
俊憲 中山
俊憲 中山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University
Original Assignee
Chiba University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University filed Critical Chiba University
Priority to JP2010190842A priority Critical patent/JP6019492B2/ja
Publication of JP2011068643A publication Critical patent/JP2011068643A/ja
Publication of JP2011068643A5 publication Critical patent/JP2011068643A5/ja
Application granted granted Critical
Publication of JP6019492B2 publication Critical patent/JP6019492B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2010190842A 2009-08-28 2010-08-27 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤 Expired - Fee Related JP6019492B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010190842A JP6019492B2 (ja) 2009-08-28 2010-08-27 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009198957 2009-08-28
JP2009198957 2009-08-28
JP2010190842A JP6019492B2 (ja) 2009-08-28 2010-08-27 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤

Publications (3)

Publication Number Publication Date
JP2011068643A JP2011068643A (ja) 2011-04-07
JP2011068643A5 JP2011068643A5 (enExample) 2013-10-10
JP6019492B2 true JP6019492B2 (ja) 2016-11-02

Family

ID=44014281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010190842A Expired - Fee Related JP6019492B2 (ja) 2009-08-28 2010-08-27 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤

Country Status (1)

Country Link
JP (1) JP6019492B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202013014RA (en) 2012-01-16 2021-02-25 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
US20140086849A1 (en) * 2012-09-21 2014-03-27 Elizabeth McKenna Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
CN105748533B (zh) * 2016-03-11 2019-08-30 青岛东海药业有限公司 副干酪乳杆菌制剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4463525B2 (ja) * 2003-10-23 2010-05-19 ビオフェルミン製薬株式会社 減感作療法用剤
JP2008255084A (ja) * 2007-04-04 2008-10-23 Isako Hashimoto 抗花粉症剤または食品

Also Published As

Publication number Publication date
JP2011068643A (ja) 2011-04-07

Similar Documents

Publication Publication Date Title
ES2399993T3 (es) Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
JP5117171B2 (ja) 抗アレルギーの乳酸菌
JP2014512388A (ja) 免疫反応を増進するための組成物および方法
JP2010502766A (ja) アジュバントとしてのキチン微粒子
CN101969966A (zh) 用于尘螨变态反应的双歧杆菌
ES2407150T3 (es) Bacteria ácido láctica novedosa con actividad anti-alérgica, agente anti-alérgico, alimento y composición farmacéutica que comprenden, cada uno de ellos, la bacteria ácido láctica, y proceso para la producción del agente anti-alérgico
JP2003261453A (ja) Ｅ．フェカリスからなる抗腫瘍剤及び放射線防護剤
CN110643541B (zh) 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN113881597B (zh) 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌
PT1461054E (pt) Preparações de bactérias gram positivas para o tratamento de doenças que implicam uma desregulação imunitária
CN116018152A (zh) 用于预防或治疗冠状病毒相关疾病和/或症状的益生菌
JP2001064174A (ja) 免疫賦活効果を相乗的に増強した製剤
JP2011068643A (ja) 乳酸菌および抗原物質を含み、口腔内に投与されることを特徴とする抗アレルギー剤
JP5531321B2 (ja) Ｉｌ−１０産生促進作用を有する免疫賦活組成物
JP7847765B2 (ja) コロナウイルス由来抗原タンパク質または当該タンパク質をコード化する遺伝子を含む細胞外小胞体およびその用途
TW201201820A (en) Use of lactic acid bacteria to treat or prevent rhinitis
CN119752686A (zh) 一株可缓解及预防变应性鼻炎的长双歧杆菌婴儿亚种及其应用
CN102028224B (zh) 抗过敏的乳酸菌
US6350457B1 (en) Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2004262773A (ja) 免疫機能改善を目的としたビフィズス菌製剤
JP4463525B2 (ja) 減感作療法用剤
CN117084410A (zh) 一种包含副干酪乳杆菌的组合物、及其经由细胞焦亡、细胞周期停滞而抑制鼻咽癌的用途
CN101686993B (zh) 卡介菌多糖核酸提取物在制备治疗病毒性皮肤病的药物中的应用及其注射剂和制备方法
TWI230611B (en) Anti-infection composition and food containing such anti-infection composition
WO2009086695A1 (zh) 卡介菌多糖核酸提取物在制备治疗变态反应性皮肤病的药物中的应用及其注射剂和制备方法

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130821

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140806

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141002

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150511

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150810

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150930

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150918

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20151016

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20151211

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160913

R150 Certificate of patent or registration of utility model

Ref document number: 6019492

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees